Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
17% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $122.8K | $79.6K | $225.9K | $59.3K | $160.2K | $167.1K | $108.9K | $98.3K |
| Cost of revenue | $0 | $43.0K | $438.1K | $207.5K | $440.5K | $197.7K | $118.8K | $56.8K |
| Gross profit | $122.8K | $36.6K | −$212.2K | −$148.2K | −$280.3K | −$30.6K | −$9.9K | $41.5K |
| Gross margin | 100.0% | 46.0% | -93.9% | -250.2% | -174.9% | -18.3% | -9.1% | 42.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$780.1K | −$869.6K | −$384.1K | −$5.1M | −$859.8K | −$78.6K | −$757.2K | −$101.7K |
| EBITDA | −$741.6K | −$869.6K | −$1.3M | −$4.9M | −$806.2K | −$23.0K | −$701.6K | −$101.7K |
| Net income | −$780.1K | −$861.0K | −$1.7M | −$5.1M | −$859.8K | −$78.6K | −$757.2K | −$48.9K |
| Net margin | -635.3% | -1081.2% | -750.1% | -8654.2% | -536.6% | -47.0% | -695.4% | -49.8% |
| EPS (diluted) | -428.18 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
CBD LIFE SCIENCES INC
No one on the platform currently holds CBDL.
No tracked institution reports a position in CBDL as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-04-22 | 1-for-300reverse |
No one on the platform has traded CBDL yet.
| $34926 |
| — |
| IVIXFInvion Limited | $0.04 | +0.00% | $4M | — |
| JUVAFJuva Life Inc. | $0.00 | +0.00% | $1641 | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 6.1× sales vs its 196.2× historical median P/S.
Fair value ≈ $0.01 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$CBDL I’m sure @tenassociates33 os pumping this turd super hard right now. Don’t buy into it. He’s littering through his gapped teeth with his google image corvette photo.
View on StockTwits ↗$CBDL Big news early next week. $0003`s are leaving seeing $0004`s
View on StockTwits ↗$CBDL OMG WTF IS THIS? .0003????? FAKE COMPANY? DILUTION SCAM? WHAT IS THIS CRAPOLA?!
View on StockTwits ↗$CBDL WAT A CRAPPY STOCK .00002 LMAO MONEY PIT.
View on StockTwits ↗$CBDL Strategic Alignment with a High-Growth Industry As the CBD market continues to grow at a rapid pace, CBD vapes are becoming a major point of differentiation for innovative companies. Their non-psychoactive properties, along with rising scientific interest and growing consumer awareness, are fueling increased demand across both retail markets and research-focused sectors. CBDL believes its early entry and focused investment in CBD product development positions the Company to: Capture first-mover advantage in an emerging CBD category Expand market share across multiple product verticals Strengthen brand authority in next-generation cannabinoid innovation Drive long-term revenue growth and shareholder value
View on StockTwits ↗$CBDL - CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes https://finance.yahoo.com/sectors/healthcare/articles/cbd-life-sciences-inc-cbdl-110000003.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.